Investor Relations FAQ
Financial information
Shareholder services
Share information
Corporate governance and sustainability
General information
Financial information
| Q. What were Novo Nordisk’s total sales in 2007? |
| A. Novo Nordisk’s total sales in 2007 were DKK 41.831 million |
| Q. What was Novo Nordisk’s net income in 2007? |
| A. Novo Nordisk’s net income in 2007 was DKK 8.522 million |
| Q. What was Novo Nordisk free cash flow in 2007? |
| A. Novo Nordisk’s free cash flow was DKK 9.012 million in 2007 |
| Q. How much did Novo Nordisk spend on Research and Development (R&D) in 2007? |
| A. Novo Nordisk spent DKK 8.538 million on R&D in 2007 |
| Q. Where do I obtain key financial information? |
| A. Click here for link to downloadable financial data |
| Q. How do I get copies of financial documents, e.g. the annual reports, quarterly reports or the form 20F? |
| A.Click here for Annual Reports, Quarterly Reports or Form 20F |
| Q. When are the next earnings release scheduled for? |
| A. Click here for link to the financial calendar |
| Q. When is the next General Annual Meeting? |
| A. Click here for link to the financial calendar |
| Q. When is Novo Nordisk’s fiscal year? |
| A. Novo Nordisk’s fiscal year is January 1 to December 31. |
Shareholder services
| Q. How or where can I buy Novo Nordisk A/S B-shares? |
| A. Novo Nordisk shares can be bought or sold through a stock broker, bank, or generally through a financial institution that provides brokerage services |
| Q. Where should I direct equerries concerning dividend payments, transfer of share certificates, consolidation of shareholder accounts and tracing of lost shares? |
| A. Outside North America: Danske Bank Holmens Kanal 2-12 1092 Copenhagen K Denmark Phone +45 3344 0000 In North America: JPMorgan Chase Bank, NA PO Box 3408 South Hackensack, NJ 07606 USA Phone: +1 800 990 1135 Phone: +1 201 680 6630 for enquiries from outside the United States |
Share information
| Q. Where can I find historical stock prices? |
| A. Click here for link to stock charts |
| Q. Where can I find information about Novo Nordisk’s stock split history, share capital history and historical dividend payments? |
| A. Click here for link to dividend and capital history |
| Q. What is the number of outstanding shares? |
| A. Click here for link to facts about the share |
| Q. What is the difference between Novo Nordisk A- and B-shares? |
| A. Click here for link to facts about the share |
| Q. On what stock exchanges are Novo Nordisk traded and what are the stock symbols? |
| A. Click here for link to facts about the share |
| Q. What are ADRs/ADSs? |
| A. ADR is an abbreviation for an American Depository Receipt. ADS is an abbreviation for an American Depository Share. An ADR is a receipt for the shares of a foreign-based corporation held in the vault of a U.S. bank, entitling the shareholder to all dividends and capital gains. An ADR is the certificate that represents a number of ADSs. |
| Q. What is Novo Nordisk cusip number for its ADRs/ADSs traded on the New York Stock Exchange? |
| A. The CUSIP number is 670100205 |
| Q. Does Novo Nordisk have a share repurchase programme? |
| A. Yes, Novo Nordisk increased the share repurchase programme January 2008, for the period 2006-2009 to DKK 16.5 billion. |
| Q. Where do I find information on apportionment of the tax basis in Novo Nordisk A/S shares held prior to the demerger between shares held in Novo Nordisk A/S and shares received in Novozymes A/S in connection with the demerger? |
| A. Click here for link to the Apportionment Document |
Corporate governance and sustainability
| Q. How do I find out more about Novo Nordisk and Corporate Governance? |
| A. Click here for link to Novo Nordisk’s Corporate Governance section |
| Q. Are there any differences between Novo Nordisk stand on Corporate Governance and the New York Stock Exchange guidelines? |
| A. Click here for link to the Corporate Governance codes |
| Q. How do I find out more about Novo Nordisk and Corporate Sustainability? |
| A. Click here for link to Novo Nordisk’s Corporate Sustainability section |
| Q. Where can I find information about Novo Nordisk’s Articles of Association? |
| A. Read Novo Nordisk’s Articles of Association in English and in Danish. |
General information
| Q. What is Novo Nordisk’s mission statement? |
| A. Click here for link to Novo Nordisk’s way of management |
| Q. Where do I find information on Novo Nordisk’s rules of conduct? |
| A. Click here for link to Novo Nordisk’s way of management |
| Q. What are Novo Nordisk’s long-term financial targets? |
A. Novo Nordisk’s long-term financial targets are:
|
| Q. Where can I obtain information on Novo Nordisk’s pipeline? |
| A. Click here for link to the pipeline |
| Q. Which accounting convention does Novo Nordisk adhere to? |
| A. As of 1 January 2004, the accounting policies have been changed to comply with International Financial Reporting Standards (IFRS). The date of transition is 1 January 2002 and all comparative figures for 2000-2003 have been restated. Following IFRS 1 all standards and interpretations effective at 31 December 2004 have been applied. Note 39 in the Annual Report 2004 makes a reconciliation to US GAAP. |
| Q. Who are Novo Nordisk’s auditor? |
| A. PriceWaterhouseCoopers |
| Q. Does Novo Nordisk have stock option programme? |
| A. Yes, please refer to note 34 in the Annual Report |
| Q. Who is Novo Nordisk’s Executive Management? |
| A. Click here for link to the Executive Management |
| Q. Who are the Investor Relations staff members? |
| A. Click here for link to Investor Relations |
